It is a pharma private limited company based in Tirumalagiri, Telangana, India, established in 2020.
2020 | Tirumalagiri, Telangana, India | ActiveIkem Pharma Private Limited, a active private limited company, was established on 07 September 2020 in Tirumalagiri, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290TG2020PTC143617. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Nagireddy Sanapalli (Director), Sanapalli Subbareddy (Director), Swapna Mukkara (Director). It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5-5-35/33/1, Ncs Complex, 2Nd Floor, Prasanthi Nagar,, Tirumalagiri, Telangana, 500072.
U24290TG2020PTC143617
143617
07 September 2020
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ikem Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagireddy Sanapalli | Director | 07 Sep 2020 | Current |
| Sanapalli Subbareddy | Director | 07 Sep 2020 | Current |
| Swapna Mukkara | Director | 07 Sep 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ikem Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 337.85% increase. The company also saw a substantial improvement in profitability, with a 87.23% increase in profit. The company's net worth Soared by an impressive increase of 63.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Ikem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2023 | Axis Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Ikem Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ikem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikem Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ikem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity Ikem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 5.00 M with Charge ID 100769359 was registered on 29 May 2023. was completed.
Nagireddy Sanapalli was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
The activity Sanapalli Subbareddy was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 5 years 4 months . was completed.
The activity Swapna Mukkara was appointed as a Director was appointed as a Director on 07 Sep 2020 & has been associated with this company since 5 years 4 months . was completed.
The CIN of Ikem Pharma Private Limited is U24290TG2020PTC143617.
Ikem Pharma Private Limited is headquartered at 5-5-35/33/1, Ncs Complex, 2Nd Floor, Prasanthi Nagar,, Tirumalagiri, Telangana, 500072.
Ikem Pharma Private Limited was incorporated on 07 September 2020.
The current directors of Ikem Pharma Private Limited are
The primary industry of Ikem Pharma Private Limited is Manufacturing.
Ikem Pharma Private Limited is unlisted.
The authorized capital of Ikem Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX